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A series of growth hormone-releasing factor analogs have been studied by both circular 
dichroism and electrospray ionization mass spectrometry (ESI/MS). The peptides are 32 
residues long and are known to adopt a random-coil structure in aqueous solution but 
become increasingly helical as the proportion of organic solvent is increased. Deuterium 
exchange was observed as an increase in mass of the peptide, as measured by ESI/MS. Rates 
of exchange were measured and half-lives calculated for analogs containing amino acid 
substitutions designed to promote or discourage helix formation. Exchange was slower in 
peptides that are helical (as shown by circular dichroism) than in randomly coiled peptides. 
Solution conditions that favor helix formation also produced slower exchange rates. These 
studies suggest that ESI/MS can provide date about the extent and stability of helix 
formation. (1 Am Sot Mass Specfrom 1993, 4, 646-651) 
F 
ew developments in protein mass spectrometry 
have had as immediate and profound an effect 
on the field as has electrospray ionization mass 
spectrometry (ES~/M~) [l, 21. The measurement of 
molecular mass up to approximately 100,000 Da with 
very high precision is now routine. A number of recent 
reports [3-&l suggest that ESI/MS may provide infor- 
mation about protein secondary structure as well. 
Charged states are distributed differently in native 
proteins than in their denatured counterparts. Re- 
cently, Katta and Chait [5] demonstrated that ESI/MS 
could be used to measure deuterium exchange into 
proteins and might therefore yield another type of 
information about secondary structure. Although elec- 
trospray mass spectra may provide clues to secondary 
structure, it remains difficult to interpret that informa- 
tion. To simplify the problem, we have been using 
ESI/MS to study a series of well-characterized peptide 
models. 
One such system involves a series of growth 
hormone-releasing factor (GRF) analogs, which we 
have investigated in an effort to understand the rela- 
tionship between primary sequence and secondary 
structure under a variety of solution conditions. GRF 
analogs have been widely studied and have been sug- 
gested as a therapy for growth hormone deficiency [91. 
The native human GRF (hGRF) is a 44-residue hy- 
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pothalamic peptide related to glucagon. An analog 
corresponding to residues l-32, with Leu in position 
27 and a C-terminal amide (LeuZ7-hGRF(-32)NH,), is 
shown in Scheme I. This peptide has been shown to 
adopt a random coil under aqueous conditions but 
becomes helical in solvent mixtures containing trifluo- 
roethanol or methanol [lo-141. The structure has been 
described, using nuclear magnetic resonance (NMR) or 
modeling studies, as being composed of either one 
long helix [ll] or two shorter helical regions [lo], 
encompassing residues 6-13 and 16-29. The remain- 
der of the peptide has been demonstrated to be a 
random coil; no other secondary structures have been 
observed. These data suggest that residues 13-16 may 
be in an unstable secondary structure and that the 
introduction of a helix-forming residue or a helix- 
breaking residue at position 15 might have a signifi- 
cant effect on overall helical structure. 
Y-A-D-A-I-F-T-N-S-Y-R-K-V-L-G-Q-L- 
S-A-R-K-L-L-Q-D-I-L-S-R-Q-Q-G-NH, 
Scheme I. Sequence of Let?‘-hGlW(l-32)NH,. 
The a-helix is the most abundant secondary struc- 
ture type in proteins overall, although individual pro- 
teins may vary in their relative amounts of helix, 
P-sheet, or random coil. We believed that the GRF 
analogs would provide a well-characterized system 
with which to explore whether ESI/MS could be uti- 
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lized to measure the extent of formation and/or the 
stability of helices in peptides. Helical content is gener- 
ally determined using circular dichroism or NMR, but 
each of these techniques has its own shortcomings. 
Experimental 
Materials 
GRF Analogs [LeuZ7-hGRF(l-32)NH,; Ala’5,Leu27- 
bovine GRF (bGRF)(-32)NH,; and ProI Leuz7- 
bGRF(l-32)NH,] were generous gifts of the Upjohn 
Company (Kalamazoo, MI). D,O (99.996%) and 
deutero(d,)-methanol (99.96%) were purchased from 
Cambridge Isotope Laboratories (Woburn, MA). 
Circular Dichroism 
Circular dichroism (CD) studies were performed on an 
AVIV 60DS spectrometer from Aviv Associates 
(Lakewood, NJ). A 0.05-cm jacketed quartz cell from 
Hellma (Forest Hills, NY) was thermostated at 25 “C. 
Complete experimental details have been published 
elsewhere [ 151. All spectra were collected on solutions 
with peptide concentrations ranging from 0.05 to 0.5 
mg/mL, using a scan range of 190-250 nm, a 0.25-nm 
step size, and a bandwidth of 1.5 nm. The mean 
residue ellipticity, 8, at 222 nm was expressed in 
degrees cm* dmol-‘. Percent helicity was calculated at 
222 m-n, using a modified formula from Greenfield and 
Fasman [16]: 
49 
Fraction helix = “” 
- %Oll 
ehelix - (qcoil 
where u!&, = - 2340, and ehelix = - 30,300 (values are 
from Chen and co-workers [17, 181 and Chakrabartty 
et al. [ 191, respectively). 
Mass Spectrometry 
Electrospray mass spectra were collected with a Sciex 
API-III mass spectrometer (Sciex, Thornhill, Ontario, 
Canada) in the positive ion mode. Samples were dis- 
solved to a concentration of approximately 10 pmol/pL 
in methanol/water (or deuteromethanol/D,O) and 
transferred as quickly as possible ( < 1 min) to a lOO-PL 
gastight syringe. Methanol concentrations were 0%, 
40%, and 80% (v/v). The solutions were unbuffered, 
and pH was not routinely measured; but the pH of an 
aqueous solution of the peptides before addition of 
methanol was 3.5. A Harvard model 22 syringe pump 
(Harvard Apparatus, South Natick, MA) was used to 
infuse the sample into the instrument at a rate of 2 
pL/min. The ion spray needle was maintained at 4800 
V, and the orifice potential was 80 V. A mass range of 
900-970, encompassing the abundant + 4 charged ion, 
was scanned continuously at 2.5 s per scan for a period 
of several minutes. 
Results and Discussion 
The model system chosen in which to study helicity 
was a pair of bGRF analogs and an hCRF analog, 
differing from each other only in positions 15 and 28. 
The hGRF analog contained a Gly15 and a Se?*, 
whereas the bGRF analogs were substituted with ei- 
ther a Pro” or an Ala15, but both contained an Asn’“. It 
was expected that the Ala”-bGRF analog would show 
increased helicity [20] relative to the native sequence 
and that the ProI analog would show decreased helic- 
ity owing to the helix-breaking character of proline 
[20]. Gly and Pro residues are generally considered to 
be helix breaking, although the effect of Pro is more 
pronounced because Pro lacks an amide proton re- 
quired to maintain the hydrogen bonding that prc- 
vides the stabilization for the helix. The proline ring is 
also not easily accommodated into a helical structure 
and has been shown to distort the helix axis [21]. The 
effect on helical content of the second alteration in 
primary sequence, at position 28, was considered mini- 
mal because of the apparent stability of the helical 
structure observed in two-dimensional NMR experi- 
ments 1151. Therefore, comparisons of helical content 
between the bGRF and hGRF analogs are probably 
justified. 
The far-TJV circular dichroic spectra of all GRF 
analogs studied showed characteristic a-helical sec- 
ondary structure (Figure 1). The appearance of the 
spectra at any given level of organic solvent was inde- 
pendent of concentration, ionic strength, and pH [15], 
indicating that the solvent-induced effect was far 
greater than the effects of pH, concentration, or ionic 
strength. Felix et al. [22] have also shown by NMR that 
the helicity of GRF analogs in methanol was not af- 
fected by changes in pH over the range 3-6. Single- 
wavelength determinations at 222 run were made and 
used to calculate OZZ2 and percent helicity. Methanol 
was chosen over 2,2,2-trifluoroethanol (TFE) because it 
160 200 220 240 260 
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Figure 1. CD spectra of Al& and Pro’“-bGRF in 80% methanol. 
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provided a weaker helix-inducing environment [23] in 
which single amino acid replacement analogs could be 
studied without being overshadowed by solvent- 
induced effects. Although we did not specifically com- 
pare the results in TFE and methanol, NMR studies 
show that there is little difference between structure of 
GRF peptides in the two solvents [lo-141. 
-4 
Pro-bGRF ESI-MS 
MW (obs.)=3719 6
MW (talc )=3720 3 
Figure 1 shows the circular dichroic spectra for the 
Ala’“-and Pro”-bGRF analogs in 80% methanol. The 
Ala15-bGRF analog showed greater helix-forming 
propensity (81% helix for Alar5-bGRF, 47% for Pro’s- 
bGRF), as would be expected considering the greater 
helix-forming character of alanine compared with pro- 
line [20]. The Alar5-bGRF and Gly”-hGRF analogs did 
not appear significantly different from each other, but 
both were considerably more helical than the Pro’s- 
bGRF analog. This trend in helix-forming ability was 
observed throughout the range of methanol concen- 
trations studied (O-SO%). These results suggest that 
residue 15 occupies a position easily modified to be- 
come helical, consistent with the findings of two- 
dimensional NMR [ 141. 
0 
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Other workers have shown that the GRF peptides 
adopt a random coil in aqueous solution but become 
more helical as the percentage of organic solvent in- 
creases [lo-121. As the percentage of water decreases, 
the hydrogen bonding to the solvent of peptide car- 
bonyls and amide nitrogens decreases, leading to 
stronger intrachain hydrogen bonding and greater heli- 
cal character [24]. This is consistent with our observa- 
tions based on CD. All three analogs showed a linear 
increase in percent helicity with increasing methanol 
concentration over the range O-80% methanol. As the 
methanol concentration increased from 0% to 80%, the 
percent helix of the Proi5-bGRF analog increased from 
7% to 47%; that of the Ala”-bGRF analog changed 
from 18% to 81%; that of the Gly”-hGRF analog 
changed from 12% to 77%. Correlation coefficients for 
the three lines ranged from 0.980 to 0.997. 
Figure 2. ES1 mass spectrum of I’d-bGRF. 
involved in hydrogen bonds, such as the bonds that 
stabilize an a-helix, will exchange more slowly. Deu- 
terium exchange of proteins is often studied by NMR. 
In an ESI/MS experiment, the exchange of protons 
with deuterons will result in the increase in measured 
molecular mass of the peptide by 1 Da per exchange 
site. The GRF analogs have 68-70 exchangeable prm 
tons and so, when fully exchanged, should show a 
shift in molecular mass of 68-70 Da. 
It is important to note that although the ESI/MS 
detects ions in the gas phase, the exchange that is 
being measured is occurring in the liquid phase, before 
the gaseous ions are formed. Because of this, we be- 
lieve that it is reasonable to compare the results of 
structural measurements from CD, NMR, and ESI/MS. 
Furthermore, with our current level of understanding, 
we cannot differentiate by ESI/MS hydrogen bonding 
in cY-helices from hydrogen bonding in P-sheets or 
other secondary structures. The GRF model was cho- 
sen because only one structural type (helix) is repre- 
sented. 
The GRF analogs were then studied by ESI/MS 
[l, z]. This relatively recent and gentle ionization 
method, in which protein solutions are sprayed in the 
presence of a high electric field, leads to the formation 
of analyte ions, often bearing multiple charges (for a 
review of electrospray, see ref 1). Figure 2 shows the 
electrospray mass spectrum of the Pro”-bGRF analog. 
The major ions are the +5 and +4 charged states at 
m /z 744.9 and 931.1, respectively. The charge on each 
ion and the mass of the intact peptide are determined 
in a straightforward fashion [U]. The accuracy and 
precision of molecular mass measurement for peptides 
of this size are quite good. In this example, a relative 
molecular mass of 3719.6 & 0.7 was measured; the 
calculated relative molecular mass based on the amino 
acid sequence, is 3720.3. 
To study the helical content of the peptides, we 
used deuterium exchange in conjunction with ESI/MS 
[5]. Protons on peptides in a random coil will exchange 
rapidly with the surrounding solvent, whereas those 
Katta and Chait [5] studied the exchange of bovine 
ubiquitin and observed a relatively slow exchange 
(62% in 20 min). The GRF analogs, presumably be- 
cause of their small size, exchange much more quickly. 
Exchange proceeds rapidly during the first 3-4 min of 
the experiment and then reaches a plateau. To obtain 
information on a rapidly changing system, a short scan 
was desirable but one in which the maximum time 
was spent on the ions of interest. Consequently, exper- 
iments were set up to scan only a limited mass range 
(m /z 900&970), encompassing the abundant t4 
charge state. Figure 3 shows the change in mass for 
the Ala’“-bGRF analog as a function of time after 
exposure to deuterated solvent (80% methanol-d,). 
There is an almost instantaneous rise in mass as the 
protons in the amino acid side chains and at the 
extreme ends of the peptide backbone exchange. The 
mass increase then slows somewhat as another popula- 
tion of protons exchange; these most likely represent 
amide protons in the peptide backbone that are in- 
volved in hydrogen bonding. After approximately 3 
min, the measured mass levels off or continues to 
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Figure 3. Change in mass-to-charge ratio of the +4 charged ion 
of AlaIs-bCRF over time after exposure to deukrated solvent 
(80% methanol in water). The fully proton&d ion would be m/z 
924.6, and the fully deuterated ion m/z 943.0. 
increase at a very slow rate. Experiments indicate that 
exchange of the last protons is still not complete even 
after several days. The very slowly exchanging protons 
probably represent amide backbone protons involved 
in very stable hydrogen bonds, as would be found 
deep within an a-helix. 
To obtain information about the rate of exchange, 
the data can be plotted as “percent hydrogen remain- 
ing” versus time (Figure 4). The exponential decay 
appears to represent pseudo-first-order kinetics and 
can be curve-fit to determine a rate constant and half- 
life. For the Ala15-bGRF analog data, the curve in 
Figure 4 shows the best fit to the expression 
y=A+BXexp(-Ct) 
and predicts a half-life of 45 s 
0 1 2 3 
Time (min) 
Figure 4. Deuterium exchange of l’ro15- and Ala”-bGW in 
deuterated solvent (80% methanol in water). Curve, y = 14.2 + 
23.5 exp( - 1.3 X t). 
Figure 4 compares the data for the exchange of the 
Pro15- and Ala’“-bGRF analogs in 80% aqueous 
methanol (both solvents deuterated). The half-life for 
the Prol’-bGRF analog is very short (- 5 s) compared 
with 45 s for Ala”-bGRF. This is consistent with the 
slower exchange of the Ala”-bGRF analog due to more 
extensive hydrogen bonding and, presumably, greater 
helical content. At lower methanol concentrations (40% 
or less), the exchange of the Pro’5-bGRF analog was 
too fast to measure (i.e., at the first time point, the 
mass was that of the fully deuterated peptide). Once 
again, the rate of exchange of the Gly”-hGRF analog 
was similar to that of Ala’“-bGRF, whereas both were 
slower than the Pro’5-bGRF analog. 
As with the CD studies, when the GRF analogs 
were studied by ESI/MS in varying concentrations of 
methanol, there was evidence of a marked change in 
structure. Figure 5 shows the exchange for the Ala15- 
bGRF analog in various solvent compositions. The 
exchange was slowest in 80% methanol and faster in 
40% and 0% methanol, consistent with the peptide 
being most helical in the high proportion of organic 
solvent and becoming increasingly random as the or- 
ganic content decreases. It should be noted that the 
rate of exchange is somewhat dependent on the sol- 
vent composition, irrespective of secondary structure, 
and the measured exchange rate is a composite of 
these two effects. 
In an attempt to directly compare the results of the 
ESI/MS and CD experiments, one must first convert to 
some common unit of measure. CD data are usually 
reported as percent helicity; that is, the number of 
residues involved in the cc-helix divided by the total 
number of residues. The ESI/MS results are reported 
here as percent of hydrogens exchanged or remaining. 
If one assumes that all side-chain protons exchange 
very quickly and that the protons on the N- and 
C-termini of the peptide also exchange immediately, 
then one can calculate the number of amide protons 
likely to be involved in hydrogen bonding and, from 
that, the percent of the total amide protons in the helix. 
For example, the Ala”-bGRF analog has a total of 70 
exchangeable protons: 35 in side chains, 2 each at the 
N- and C-termini (the C-terminus is amidated), and 31 
in the amide backbone. Only the latter are used to 
compute percent helicity. Of the amide backbone pro- 
tons, the first four from the N-terminus cannot be 
involved in hydrogen bonding because they have no 
carbonyl partners and so would be expected to ex- 
change immediately with solvent. In 80% methanol 
(deuterated), after 4 min, we estimate that a total of 61 
(87%) hydrogens have exchanged (see Figure 4). Nine 
of a possible 31 amide protons are not exchanged and 
are therefore presumed to be involved in the helix. We 
also include the four protons at the start of the helix, 
which must be present, although we will not observe 
them in ESI/MS, bringing the total to 13 of a possible 
32. (The N-terminus of the peptide was not included in 
the count of 31 amide protons but would be included 
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Figure 5. Deuterium exchange of Ala15-bGRF as a function of 
solvent composition. Data points taken at O%, 40%, and 80% 
methanol in water (all solvents deuterated). 
in the total residues in the peptide.) We would report 
the helical content under these conditions as 41%. 
In this same concentration of methanol (SO%), the 
CD experiments measure a helical content of 81%, 
significantly higher than the number obtained from 
ESI/MS. This pattern of underestimation by ESI/MS 
was observed for all analogs at all methanol concentra- 
tions and is therefore likely to be a real effect. We 
believe that the most reasonable explanation for this 
phenomenon is that CD measures a time-averaged 
helical content, whereas ESI/MS measures exchanged 
protons. If a portion of the helix was rapidly unfolding 
and refolding, CD would measure it as helical. With 
ESI/MS, however, as a portion of the helix unfolds, its 
protons would exchange, and, regardless of whether it 
refolded again or not, it would no longer be recorded 
as helical. It is likely that the magnitude of the discrep- 
ancy between the ESI/MS and CD results reflects the 
stability of the helix, although much more study will 
be required before such stability information is inter- 
pretable. 
Conclusions 
Hydrogen exchange followed by ESI/MS appears to 
be a sensitive and useful method for observing sec- 
ondary structure in peptides. For the GRF analogs 
studied, the ESI/MS results were obtained with ap- 
proximately 200 pmol of peptide (700 ng per experi- 
ment) and correlated well with the data obtained by 
CD, although the estimates of percent helicity by 
ESI/MS are lower than those obtained by CD. Amino 
acid substitution that promotes (Ala) or inhibits (Pro> 
helix formation resulted in slower or faster exchange, 
respectively. Solution conditions known to promote 
helix formation caused slower exchange than observed 
for solutions in which the peptides are known to adopt 
a random configuration. ESI/MS measurements pro- 
vide information about the rate of exchange and the 
extent of exchange. In combination with the informa- 
tion obtained from CD, the exchange data may yield 
clues as to both the amount and the stability of sec- 
ondary structure. NMR measurements of the helicity 
of both sets of GRF analogs are under way and will be 
reported separately. 
Both CD and ESI/MS measure global helicity rather 
than localizing where in the peptide the helix occurs. 
NMR can provide specific information about the in- 
volvement of each individual amino acid in the helix 
but requires more material than either CD or ESI/MS. 
In an effort to gain information about where the helical 
regions are, we are currently exploring tandem mass 
spectrometry (MS/MS) in conjunction with deuterium- 
exchange ESI/MS. The fact that the mass of the pep- 
tide appears to plateau after the first 5 min of the 
exchange experiment may allow one to perform 
MS/MS analysis on the multiply charged parent ions, 
localizing where the deuterium atoms are incorpo- 
rated. Analysis of the MS/MS data is continuing but is 
complicated by the fact that various multiply charged 
product ions ( + 1, + 2, and + 3) are present. 
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